Hydrochloric Acid → HCID 86753945, compound
Reaction equation
[Cl:1][C:2]1[C:7]2[C:8](=[O:32])[N:9]3[CH2:31][CH2:30][CH2:29][C@H:10]3[C:11]3[N:12]([CH:13]=[N:14][C:15]=3[C:16]3[O:17][C:18]([CH2:21][N:22]([CH2:26][CH:27]=[CH2:28])[CH2:23][CH:24]=[CH2:25])=[CH:19][N:20]=3)[C:6]=2[CH:5]=[CH:4][CH:3]=1.Cl>C(O)C>[ClH:1].[Cl:1][C:2]1[C:7]2[C:8](=[O:32])[N:9]3[CH2:31][CH2:30][CH2:29][C@H:10]3[C:11]3[N:12]([CH:13]=[N:14][C:15]=3[C:16]3[O:17][C:18]([CH2:21][N:22]([CH2:23][CH:24]=[CH2:25])[CH2:26][CH:27]=[CH2:28])=[CH:19][N:20]=3)[C:6]=2[CH:5]=[CH:4][CH:3]=1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
1.15 g (0.00255 mol) of (S)-8-chloro-1-(5-diallylaminomethyl-oxazol-2-yl)-11,12,13,13a-tetrahydro-9H-imidazo[1,5-a]pyrrolo[2,1-c][1,4]benzodiazepin-9-one in 20 ml of ethanol were treated with 0.53 ml (0.00253 mol) of 4.78N ethanolic hydrochloric acid at 0°. After stirring at 0° for 10 minutes the colorless solution was completely freed from the solvents. The residue was dissolved in hot ethanol and recrystallized by the addition of ether. There was obtained 0.9 g (78%) of (S)-8-chloro-1-(5-diallylaminomethyl-oxazol-2-yl)-11,12,13,13a-tetrahydro-9H-imidazo[1,5-a]pyrrolo[2,1-c][1,4]benzodiazepin-9-one hydrochloride (1:1) as beige crystals; m.p. 169°-171° and [α]D20 =+7.70 (MeOH, c=1%).
Workup
- customrecrystallized by the addition of ether
Sources & evidence
- ORD record
- ord-f0e1542eeea64199b4ec36072cc54db3
- Source dataset
- uspto-grants-1999_03
- Patent number
- US05885986
Reaction notes
Loading…